Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-09-09), Megaforce Co's 1-Year Sharpe Ratio is -0.89.
Megaforce Co (ROCO:3294) 1-Year Sharpe Ratio Explanation
The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.
The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.
Megaforce Co 1-Year Sharpe Ratio Related Terms
ROCO:3294 vs APH, GLW, TEL: 1-Year Sharpe Ratio Comparison
For the Electronic Components subindustry, Megaforce Co's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Megaforce Co 1-Year Sharpe Ratio vs Hardware Industry
For the Hardware industry and Technology sector, Megaforce Co's 1-Year Sharpe Ratio distribution charts can be found below:
* The bar in red indicates where Megaforce Co's 1-Year Sharpe Ratio falls into.
The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.
Megaforce Co (ROCO:3294) has a 1-Year Sharpe Ratio of -0.89 as of Sep. 09, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Megaforce Co and its competitors.
Is Megaforce Co's 1-Year Sharpe Ratio too high?
Megaforce Co's current 1-Year Sharpe Ratio is -0.89. Overall, Megaforce Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Megaforce Co's 1-Year Sharpe Ratio compare to APH and GLW?
Megaforce Co's 1-Year Sharpe Ratio of -0.89 can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Hardware company?
A good 1-Year Sharpe Ratio depends on the Hardware industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Megaforce Co and its competitors. Megaforce Co's current 1-Year Sharpe Ratio is -0.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Megaforce Co stock overvalued right now?
Based on GuruFocus' analysis, Megaforce Co (ROCO:3294) is currently considered Fairly Valued. The stock's GF Value™ is NT$29.19, compared to a current price of NT$29.70 — trading 1.7% above its estimated fair value. The current 1-Year Sharpe Ratio is -0.89. Megaforce Co's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Megaforce Co (ROCO:3294), the current 1-Year Sharpe Ratio is -0.89 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Megaforce Co (ROCO:3294) Overvalued in 2026?
Based on GuruFocus' analysis, Megaforce Co stock appears to be overvalued.
The current stock price of NT$29.70 is trading 1.7% above its estimated GF Value™ of NT$29.19.
GuruFocus considers Megaforce Co to be Fairly Valued.
Key valuation signals for ROCO:3294:
1-Year Sharpe Ratio: -0.89
GF Value™: NT$29.19 vs. price of NT$29.70 (1.7% above fair value)
No single metric tells the full story. See the ROCO:3294 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Megaforce Co Ltd is engaged in the manufacture and sales of plastic injection molds, tooling manufacturing, and general import and export trade. The Group's reportable segments comprise the Precision electronics manufacturing segment, the Biomedical and system integration segment, the Fortis biosolutions segment, the Opto-mechatronics segment, and AI application development segment, all of which are the Group's strategic business units (SBUs) that provide different products and services such as design, manufacture, and sale of plastic components, medical devices, opto-mechatronics products and AI application products. The company generates the majority of its revenue from products such as Plastic injections, tools, and others.
62GF Score
Get the complete analysis for ROCO:3294
1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:3294 has been successfully added to your 
